• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格列美脲在环糊精 - 聚合物体系中的包合作用对其溶出度、稳定性及治疗效果的影响。

Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.

作者信息

Ammar H O, Salama H A, Ghorab M, Mahmoud A A

机构信息

Department of Pharmaceutical Technology, National Research Center, Dokki, Cairo, Egypt.

出版信息

Int J Pharm. 2006 Aug 31;320(1-2):53-7. doi: 10.1016/j.ijpharm.2006.04.002. Epub 2006 Apr 18.

DOI:10.1016/j.ijpharm.2006.04.002
PMID:16701974
Abstract

The effect of complexation of glimepiride, a poorly water-soluble antidiabetic drug, with beta-cyclodextrin and its derivatives (HP-beta-CyD and SBE-beta-CyD) in presence of different concentrations of water-soluble polymers (HPMC, PVP, PEG 4000 and PEG 6000) on the dissolution rate of the drug has been investigated. The results revealed that the dissolution rate of the drug from these ternary systems is highly dependent on polymer type and concentration. The dissolution rate of the drug from ternary systems containing PEG 4000 or PEG 6000 seems to be generally higher than from systems containing HPMC or PVP. An optimum increase in the dissolution rate of the drug was observed at a polymer concentration of 5% for PEG 4000 or PEG 6000 and at 20% concentration of HPMC or PVP. The dissolution rate of the drug from the ternary system glimepiride-HP-beta-CyD-5% PEG 4000 was high compared to the other systems. Tablets containing the drug or its equivalent amount of this ternary system were prepared and subjected to accelerated stability testing at 40 degrees C/75% R.H. to investigate the effect of storage on the chemical stability as well as therapeutic efficacy of the tablets. The results revealed stability of the tablets and consistent therapeutic efficacy on storage.

摘要

研究了在不同浓度水溶性聚合物(羟丙基甲基纤维素、聚乙烯吡咯烷酮、聚乙二醇4000和聚乙二醇6000)存在下,难溶性抗糖尿病药物格列美脲与β-环糊精及其衍生物(羟丙基-β-环糊精和磺丁基醚-β-环糊精)的络合对药物溶出速率的影响。结果表明,药物从这些三元体系中的溶出速率高度依赖于聚合物的类型和浓度。含有聚乙二醇4000或聚乙二醇6000的三元体系中药物的溶出速率似乎通常高于含有羟丙基甲基纤维素或聚乙烯吡咯烷酮的体系。当聚乙二醇4000或聚乙二醇6000的聚合物浓度为5%,羟丙基甲基纤维素或聚乙烯吡咯烷酮的浓度为20%时,观察到药物溶出速率有最佳增加。与其他体系相比,格列美脲-羟丙基-β-环糊精-5%聚乙二醇4000三元体系中药物的溶出速率较高。制备了含有该药物或其等量该三元体系的片剂,并在40℃/75%相对湿度下进行加速稳定性试验,以研究储存对片剂化学稳定性以及治疗效果的影响。结果表明片剂具有稳定性,储存时治疗效果一致。

相似文献

1
Implication of inclusion complexation of glimepiride in cyclodextrin-polymer systems on its dissolution, stability and therapeutic efficacy.格列美脲在环糊精 - 聚合物体系中的包合作用对其溶出度、稳定性及治疗效果的影响。
Int J Pharm. 2006 Aug 31;320(1-2):53-7. doi: 10.1016/j.ijpharm.2006.04.002. Epub 2006 Apr 18.
2
Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.格列美脲-环糊精-聚合物体系的制剂与生物学评价
Int J Pharm. 2006 Feb 17;309(1-2):129-38. doi: 10.1016/j.ijpharm.2005.11.024. Epub 2005 Dec 27.
3
Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethylcellulose complexes.格列齐特β-环糊精-羟丙基甲基纤维素复合物的溶解度及降血糖活性研究
Pharmazie. 2002 Mar;57(3):191-3.
4
Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.环糊精聚合物的可溶性和不溶性对羟丙甲纤维素片药物释放的影响。
Drug Dev Ind Pharm. 2009 Oct;35(10):1264-70. doi: 10.1080/03639040902882306.
5
In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets.长春西汀-环糊精-酒石酸多组分复合物在羟丙甲纤维素可膨胀片上的体外控释
J Control Release. 2005 Mar 21;103(2):325-39. doi: 10.1016/j.jconrel.2004.12.001. Epub 2004 Dec 23.
6
Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.含吡罗昔康和吡罗昔康 - 羟丙基 -β-环糊精包合物的羟丙基甲基纤维素微球
Pharmazie. 2004 Sep;59(9):686-91.
7
Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.亲水聚合物对异搏定与羟丙基-β-环糊精包合作用的影响。
Drug Dev Ind Pharm. 2013 Jul;39(7):970-7. doi: 10.3109/03639045.2012.686508. Epub 2012 May 21.
8
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.他达拉非与天然及化学修饰的β-环糊精的包合物。I:制备及体外评价
Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.
9
Phase solubility behavior of hydrophilic polymer/cyclodextrin/lansoprazole ternary system studied at high polymer concentration and by response surface methodology.高聚合物浓度下亲水聚合物/环糊精/兰索拉唑三元体系的相溶解度行为及响应面法研究。
Pharm Dev Technol. 2012 Mar-Apr;17(2):236-41. doi: 10.3109/10837450.2010.531738. Epub 2010 Nov 10.
10
Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.溶液和固态中扎来普隆与环糊精和亲水性聚合物的络合的比较分析。
J Pharm Biomed Anal. 2012 Dec;71:35-44. doi: 10.1016/j.jpba.2012.07.027. Epub 2012 Jul 31.

引用本文的文献

1
Optimization of Potential Nanoemulgels for Boosting Transdermal Glimepiride Delivery and Upgrading Its Anti-Diabetic Activity.用于促进格列美脲经皮递送并提升其抗糖尿病活性的潜在纳米乳凝胶的优化
Gels. 2023 Jun 18;9(6):494. doi: 10.3390/gels9060494.
2
Formulation and processing of solid self-emulsifying drug delivery systems (HME S-SEDDS): A single-step manufacturing process via hot-melt extrusion technology through response surface methodology.固体自乳化药物传递系统(热熔挤出 S-SEDDS)的制剂和加工:通过响应面法的热熔挤出技术的一步法制造工艺。
Int J Pharm. 2023 Jun 25;641:123055. doi: 10.1016/j.ijpharm.2023.123055. Epub 2023 May 18.
3
Development of Fenofibrate/Randomly Methylated β-Cyclodextrin-Loaded Eudragit RL 100 Nanoparticles for Ocular Delivery.
非诺贝特/随机甲基化 β-环糊精包载入羟丙甲纤维素 RL100 纳米粒的眼部给药系统研究。
Molecules. 2022 Jul 25;27(15):4755. doi: 10.3390/molecules27154755.
4
Glimepiride-Loaded Nanoemulgel; Development, In Vitro Characterization, Ex Vivo Permeation and In Vivo Antidiabetic Evaluation.格列美脲载纳米乳凝胶的研制、体外特性考察、体外渗透及体内抗糖尿病评价。
Cells. 2021 Sep 13;10(9):2404. doi: 10.3390/cells10092404.
5
Physicochemical Characterization, Molecular Docking, and Dissolution of Glimepiride-Captisol Inclusion Complexes.格列美脲-磺丁基醚-β-环糊精包合物的物理化学表征、分子对接及溶出度研究
ACS Omega. 2020 Aug 4;5(32):19968-19977. doi: 10.1021/acsomega.0c01228. eCollection 2020 Aug 18.
6
Experimental and molecular modeling approach to optimize suitable polymers for fabrication of stable fluticasone nanoparticles with enhanced dissolution and antimicrobial activity.采用实验和分子建模方法优化合适的聚合物,以制备具有增强溶解性和抗菌活性的稳定氟替卡松纳米颗粒。
Drug Des Devel Ther. 2018 Feb 5;12:255-269. doi: 10.2147/DDDT.S148912. eCollection 2018.
7
The Impact of Amorphisation and Spheronization Techniques on the Improved & Performance of Glimepiride Tablets.无定形化和球化技术对格列美脲片性能改善的影响
Adv Pharm Bull. 2017 Dec;7(4):557-567. doi: 10.15171/apb.2017.067. Epub 2017 Dec 31.
8
Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique.利用微乳技术提高难溶性格列美脲的口服生物利用度。
Int J Nanomedicine. 2016 Aug 5;11:3777-88. doi: 10.2147/IJN.S105419. eCollection 2016.
9
Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.依折麦布与羟丙基-β-环糊精及亲水性辅料制剂的水溶解度改善及抗高胆固醇活性
AAPS PharmSciTech. 2016 Apr;17(2):272-83. doi: 10.1208/s12249-015-0344-7. Epub 2015 Jun 16.
10
Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins.Δ9-四氢大麻醇半琥珀酸酯前药与改性β-环糊精包合物的制备与表征。
AAPS PharmSciTech. 2010 Jun;11(2):509-17. doi: 10.1208/s12249-010-9401-4. Epub 2010 Mar 24.